27 May 2021
Meta-analysis of elective coronary revascularization versus medical therapy alone - EuroPCR 2021 interview
Summary
Luis Ortega Paz interviews Eliano Navarese, lead investigator of this meta-analysis of elective coronary revascularization versus medical therapy alone, released as a late-breaking trial at EuroPCR 2021:
- The gap in evidence that motivated this systematic review and meta-analysis
- The methodology employed
- The main findings
- How will these results impact clinical practice?
View the slides of the Late-Breaking Trial presentation presented by Eliano Navarese here.
Read a review of the European Heart Journal article by Elad Asher:
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis